Our Future Health is a British health research project which aims to recruit 5 million people "to develop new ways to prevent, detect and treat diseases". [1] [2] [3] [4] It is a registered charity in England and Wales [5] and in Scotland, [6] and a private limited company. [7] The charity and company were originally known as Early Disease Detection Research Project UK (EDRP UK) and the project as Accelerating Detection of Disease (ADD). [8] [9]
The project aims to improve the early diagnosis and treatment of diseases. The project chair, Sir John Bell, said that the project aims "to try and create a sandbox for testing and evaluating these early diagnostic or prevention strategies across a large population of people ... And we'll be able to use that population to help us evaluate these new tools, diagnose disease early, prevent disease more effectively, and intervene at an earlier stage". [2]
Participation in the project is open to anyone aged over 18 and living in the United Kingdom. Participants are asked to complete a questionnaire about their health and lifestyle, and to attend a clinic to give a blood sample and have physical measurements taken. [10] Clinics to enrol people into the project and take the initial blood sample were set up at venues including university campuses [11] and branches of Boots, [12] and people taking part in NHS Blood and Transplant may also choose to enrol. [13]
De-identified data and samples provided by participants are shared with approved researchers at universities and in industry. [14] [15] Part of each blood sample is used for DNA analysis, with the results stored in the participant's record; the project may also use SNP array and genomic sequencing methods. [10] Specific genetic data, linked to the individual, may be shared with NHS Blood and Transplant. [16]
Participation continues throughout the individual's lifetime and after their death [16] but volunteers may withdraw from the project at any time. [17] As well as providing samples and personal data from questionnaires, surveys and feedback, participants agree to allow the project to access their present and future records held by the NHS. [16]
The project has the support of the government, the life sciences industry, the NHS, and charities such as Alzheimer's Society, British Heart Foundation, and Cancer Research UK. [2] £79 million was provided by the UK government via the UK Research and Innovation body, and in early 2022 a further £100 million was expected from the life sciences industry. [14]
Recruitment to the study began in late 2022. [18] In November 2023, it was announced that Our Future Health had recruited 1 million volunteers. [19] The same month it was announced that data on the first 100,000 volunteers suggested that "Most adults in the UK should be receiving treatment for high cholesterol but are not, while a quarter have untreated high blood pressure". [20] In October 2024 it was announced that 1 million volunteers had given blood samples. Dr Raghib Ali, the CEO of Future Health, said "We can now say that Our Future Health is the world's largest health research programme of its kind. No other programme has collected this many blood samples for long-term research." [21] [22]
The name "Our Future Health" and the visual branding (using "A mosaic of simple patterned tiles that can be combined and configured in endless variation and at different scales") were developed with Manchester-based branding company True North. [23]
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
UK Biobank is a large long-term biobank study in the United Kingdom (UK) which is investigating the respective contributions of genetic predisposition and environmental exposure to the development of disease. It began in 2006. UK Biobank has been cited as an important resource for cancer research.
The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.
Alzheimer's Society is a United Kingdom care and research charity for people with dementia and their carers. It operates in England, Wales and Northern Ireland, while its sister charities Alzheimer Scotland and Alzheimer Society of Ireland cover Scotland and the Republic of Ireland respectively.
Marie Curie is a registered charitable organisation in the United Kingdom which provides hospice care and support for anyone with an illness they are likely to die from, and those close to them, and campaigns for better support for dying people. It was established in 1948, the same year as the National Health Service (NHS).
The King's Trust is a United Kingdom-based charity founded in 1976 by King Charles III to help vulnerable young people get their lives on track. It supports 11-to-30-year-olds who are unemployed or struggling at school and at risk of exclusion. Many of the young people helped by the trust face issues such as homelessness, disability, mental health problems, or trouble with the law.
Liverpool Women's NHS Foundation Trust runs Liverpool Women's Hospital, a major obstetrics, gynaecology and neonatology research hospital in Liverpool, England. It is one of several specialist hospitals located within the Liverpool City Region; alongside Alder Hey Children's Hospital, Liverpool Heart and Chest Hospital, the Walton Centre, Mersey Regional Burns and Plastic Surgery Unit, and Clatterbridge Cancer Centre.
Alder Hey Children's Hospital is a children's hospital and NHS foundation trust in West Derby, Liverpool, England. It is one of the largest children's hospitals in the United Kingdom, and one of several specialist hospitals within the Liverpool City Region, alongside the Royal Liverpool University Hospital, Liverpool Women's Hospital, Liverpool Heart and Chest Hospital, the Walton Centre, Mersey Regional Burns and Plastic Surgery Unit, and Clatterbridge Cancer Centre.
The Guide Dogs for the Blind Association, known colloquially as Guide Dogs, is a British charitable organisation that uses guide dogs to help blind and partially blind people. The organisation also participates in political activism for the rights of those with vision impairments.
Blood Cancer UK, is a UK-based charity dedicated to funding research into all blood cancers including leukaemia, lymphoma and myeloma, as well as offering information and support to blood cancer patients.
Generation Scotland is a biobank, a resource of biological samples and information on health and lifestyle from thousands of volunteer donors in Scotland.
Wellbeing of Women is the only UK charity dedicated to funding research, education and advocacy across all of women's reproductive and gynaecological health, including menstruation, fertility, pregnancy, childbirth, gynaecological cancers, menopause and incontinence. It raises money to invest in medical research and the development of specialist doctors and nurses working in these fields. The charity also disseminates information and hosts regular webinars on women's health.
The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.
John Eric Deanfield is a British professor of cardiology and past Olympic fencer.
Unlimit Health is an international organisation working to end parasitic disease. The organisation partners with affected countries, sharing evidence and expertise to eliminate preventable infections, through technical and financial support to ministries of health, in line with their strategies and plans, to strengthen health systems within affected communities.
The Christie, formerly known as Christie Hospital and The Christie Hospital and Holt Radium Institute, is a specialist National Health Service oncology hospital in Manchester, England. It is one of the largest cancer treatment centres in Europe. It is managed by The Christie NHS Foundation Trust, which as of 2024 had a turnover of £472 million and around 3,500 staff, and its work is also supported by The Christie Charity.
LGBT Foundation is a national charity based in Manchester with a wide portfolio of services. With a history dating back to 1975, it campaigns for a fair and equal society where all lesbian, gay, bisexual and trans (LGBTQ) people are able to reach their full potential. They support over 40,000 people directly every year, and a further 600,000 online. They provide direct services and resources to more LGBT people than any other charity of its kind in the UK.
Eleni Nastouli is a Greek clinical virologist who works at University College London Hospitals NHS Foundation Trust (UCLH) and Great Ormond Street Hospital. At UCLH, Nastouli leads the Advanced Pathogen Diagnostics Unit, where she develops technologies for genome sequencing as well as studying how viruses are transmitted around hospitals. During the COVID-19 pandemic Nastouli led an investigation into infection rates amongst healthcare workers.
The Platform Adaptive Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community is a clinical trial in the United Kingdom to test the effectiveness of new antiviral drugs at the early stages of COVID-19 infections. The study aims to find out if antivirals can prevent the need for hospitalisation and help faster recovery for people aged over 50 and those at higher risk due to underlying health conditions. PANORAMIC is sponsored by the University of Oxford and funded by the National Institute for Health and Care Research (NIHR). The trial was launched in December 2021, and as of June 2022, over 25,000 people are enrolled as participants.